New gel shows promise for rare genetic disorder in kids
NCT ID NCT05149898
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a gel called ZYN002, applied to the skin, in 20 children and teens (ages 4-17) with 22q11.2 deletion syndrome. The main goal was to see if the gel is safe and tolerable over 38 weeks. Researchers also looked at whether it could improve behavior and other symptoms related to the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 22Q11.2 DELETION SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Genetics Clinics Australia
Melbourne, Victoria, 3161, Australia
-
Greenwood Genetic Center
Greenville, South Carolina, 29605, United States
-
Lady Cilento Children's Hospital - South Brisbane
Brisbane, Queensland, 4101, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hunting for hidden genes that shape a genetic Disorder's severity
- New prenatal blood test aims to detect genetic disorders without invasive procedures
- Brain and eye clues to emotion recognition in autism and psychosis
- Intensive brain training shows promise for kids with developmental delays
- Could a headset boost brainpower in teens with a rare genetic condition?